{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T17:27:49Z","timestamp":1787074069445,"version":"build-2736575974"},"reference-count":99,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":203,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine the role of patient-reported outcome measures (PROMs) in clinical decision-making across three inflammatory arthritides: RA, PsA and axial SpA (axSpA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic review of four online medical literature databases (MEDLINE, Embase, CINAHL, Cochrane Central) from inception to February 2025. Abstracts and full texts were independently double-assessed. Articles examining the use and influence of PROMs on RA, PsA and axSpA clinical decision-making were included, with extracted data narratively synthesised (PROSPERO registration: CRD42024550525).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 16\u2009950 identified studies, 29 were included (n\u2009=\u200922 RA, n\u2009=\u20094 axSpA, n\u2009=\u20093 PsA; study design: n\u2009=\u200915 trials, n\u2009=\u200910 cohort, n\u2009=\u20094 cross-sectional). PROMs supported three aspects of healthcare: treatment decision-making (n\u2009=\u200924), clinical encounters (n\u2009=\u20092) and self-monitoring (n\u2009=\u20096). Treat-to-target studies (n\u2009=\u200914\/24, commonly RA) used PROMs to guide drug alterations. However, clinicians adhered less to PROM-based treatment protocols for complex patients or those with restricted insurance policies. PROMs improved patient communication and trust in clinicians. PROM-based self-monitoring matched standard care outcomes, but service limitations reduced its efficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PROMs capture valuable patient data and show potential to support clinical decision-making, particularly in RA patients. Current PROM implementation methods are varied. Standardisation could maximise the clinical value of PROM data that, if acted upon, could enhance patient care and outcomes. However, service and clinician barriers, combined with poor standardisation, currently risk these data being underutilised.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rap\/rkag093","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:52:53Z","timestamp":1784807573000},"source":"Crossref","is-referenced-by-count":0,"title":["Patient-reported outcome measures (PROMs) and clinical decision-making in inflammatory rheumatic conditions: a systematic review"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5715-1342","authenticated-orcid":false,"given":"Jake","family":"Grange","sequence":"first","affiliation":[{"name":"Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9213-2796","authenticated-orcid":false,"given":"James A","family":"Prior","sequence":"additional","affiliation":[{"name":"Midlands Partnership University NHS Foundation Trust Department of Rheumatology, Haywood Hospital, , Staffordshire,","place":["UK"]},{"name":"School of Medicine, Keele University , Staffordshire,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5531-1680","authenticated-orcid":false,"given":"Jon","family":"Packham","sequence":"additional","affiliation":[{"name":"Midlands Partnership University NHS Foundation Trust Department of Rheumatology, Haywood Hospital, , Staffordshire,","place":["UK"]},{"name":"School of Medicine, Keele University , Staffordshire,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7458-4473","authenticated-orcid":false,"given":"Max","family":"Somer","sequence":"additional","affiliation":[{"name":"Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2765-3728","authenticated-orcid":false,"given":"Helen","family":"Parsons","sequence":"additional","affiliation":[{"name":"Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5405-187X","authenticated-orcid":false,"given":"Kirstie L","family":"Haywood","sequence":"additional","affiliation":[{"name":"Warwick Medical School, University of Warwick , Coventry,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"2026081812493049000_rkag093-B1","doi-asserted-by":"crossref","first-page":"100519","DOI":"10.1016\/j.lanepe.2022.100519","article-title":"Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: an observational study using primary care electronic health record data","volume":"23","author":"Scott","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2026081812493049000_rkag093-B2","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","article-title":"The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review","volume":"41","author":"Almutairi","year":"2021","journal-title":"Rheumatol Int"},{"key":"2026081812493049000_rkag093-B3","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/rheumatology\/keae198","article-title":"The worldwide prevalence of psoriatic arthritis\u2014a systematic review and meta-analysis","volume":"63","author":"Lembke","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026081812493049000_rkag093-B4","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.22831","article-title":"Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis","volume":"68","author":"Stolwijk","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026081812493049000_rkag093-B5","first-page":"736","article-title":"Rheumatoid arthritis is getting less frequent\u2014results of a nationwide population-based cohort study","volume":"56","author":"Abhishek","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2026081812493049000_rkag093-B6","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/rheumatology\/kes324","article-title":"Prevalence and treatment patterns of psoriatic arthritis in the UK","volume":"52","author":"Ogdie","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2026081812493049000_rkag093-B7","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12891-015-0853-2","article-title":"The prevalence of axial spondyloarthritis in the UK: a cross-sectional cohort study","volume":"16","author":"Hamilton","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"2026081812493049000_rkag093-B8","doi-asserted-by":"crossref","first-page":"e000656","DOI":"10.1136\/rmdopen-2018-000656","article-title":"Distinguishing rheumatoid arthritis from psoriatic arthritis","volume":"4","author":"Merola","year":"2018","journal-title":"RMD Open"},{"key":"2026081812493049000_rkag093-B9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.semarthrit.2020.10.010","article-title":"Health-related quality of life in early psoriatic arthritis compared with early rheumatoid arthritis and a general population","volume":"51","author":"Geijer","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2026081812493049000_rkag093-B10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.rdc.2020.01.017","article-title":"(Health-related) quality of life as an outcome in studies of axial spondyloarthritis","volume":"46","author":"Kiltz","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"key":"2026081812493049000_rkag093-B11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40744-020-00217-4","article-title":"Rheumatoid arthritis: the impact of mental health on disease: a narrative review","volume":"7","author":"Lwin","year":"2020","journal-title":"Rheumatol Ther"},{"key":"2026081812493049000_rkag093-B12","doi-asserted-by":"crossref","first-page":"e0218831","DOI":"10.1371\/journal.pone.0218831","article-title":"Severity of fatigue in people with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis \u2013 results of a cross-sectional study","volume":"14","author":"Pilgaard","year":"2019","journal-title":"PLoS One"},{"key":"2026081812493049000_rkag093-B13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.35975\/apic.v29i1.2663","article-title":"Arthritis cannot break my spirit: functional disability, social support and life orientation in patients with rheumatoid arthritis","volume":"29","author":"Zulfiqar","year":"2025","journal-title":"Anaesth Pain Intensive Care"},{"key":"2026081812493049000_rkag093-B14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/annrheumdis-2020-216999","article-title":"Use of multidimensional composite scores in rheumatology: parsimony versus subtlety","volume":"80","author":"Landew\u00e9","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2026081812493049000_rkag093-B15","doi-asserted-by":"crossref","first-page":"6642486","DOI":"10.1155\/2021\/6642486","article-title":"Correlation between C-reactive protein to albumin ratio and disease activity in patients with axial spondyloarthritis","volume":"2021","author":"Zhong","year":"2021","journal-title":"Dis Markers"},{"key":"2026081812493049000_rkag093-B16","doi-asserted-by":"crossref","first-page":"SI92","DOI":"10.1093\/rheumatology\/keab764","article-title":"The role of tender and swollen joints for the assessment of inflammation in PsA using ultrasound","volume":"61(SI)","author":"Bosch","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026081812493049000_rkag093-B17","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s11136-020-02692-2","article-title":"Patient-reported experience with patient-reported outcome measures in adult patients seen in rheumatology clinics","volume":"30","author":"Lapin","year":"2021","journal-title":"Qual Life Res"},{"key":"2026081812493049000_rkag093-B18","doi-asserted-by":"crossref","first-page":"e001707","DOI":"10.1136\/rmdopen-2021-001707","article-title":"Use and detailed metric properties of patient-reported outcome measures for rheumatoid arthritis: a systematic review covering two decades","volume":"7","author":"K\u00fc\u00e7\u00fckdeveci","year":"2021","journal-title":"RMD Open"},{"key":"2026081812493049000_rkag093-B19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","article-title":"A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative","volume":"73","author":"Gossec","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2026081812493049000_rkag093-B20","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"2026081812493049000_rkag093-B21","first-page":"S100","article-title":"The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis","volume":"23","author":"Aletaha","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"2026081812493049000_rkag093-B22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/rheumatology\/keac213","article-title":"New indicator for discordance between patient-reported and traditional disease activity outcomes in patients with early rheumatoid arthritis","volume":"62","author":"Pazmino","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026081812493049000_rkag093-B23","first-page":"163","article-title":"Does routine assessment and real-time feedback improve cancer patients\u2019 psychosocial well-being?","volume":"15","author":"Boyes","year":"2006","journal-title":"Eur J Cancer Care (Engl)"},{"key":"2026081812493049000_rkag093-B24","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1200\/JCO.2004.06.078","article-title":"Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial","volume":"22","author":"Velikova","year":"2004","journal-title":"J Clin Oncol"},{"key":"2026081812493049000_rkag093-B25","first-page":"573","article-title":"Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review","volume":"29","author":"Graupner","year":"2021","journal-title":"Support Care Cancer"},{"key":"2026081812493049000_rkag093-B26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J Clin Oncol"},{"key":"2026081812493049000_rkag093-B27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2753.2006.00650.x","article-title":"Impact of patient-reported outcome measures on routine practice: a structured review","volume":"12","author":"Marshall","year":"2006","journal-title":"J Eval Clin Pract"},{"key":"2026081812493049000_rkag093-B28","first-page":"CD011119","article-title":"Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults","volume":"7","author":"Kendrick","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2026081812493049000_rkag093-B29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/jmrs.421","article-title":"A review of the barriers to using patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs) in routine cancer care","volume":"68","author":"Nguyen","year":"2021","journal-title":"J Med Radiat Sci"},{"key":"2026081812493049000_rkag093-B30","first-page":"keae163","article-title":"P065 Patient-initiated follow up in rheumatoid arthritis: a systematic review and meta-analysis","volume":"63(Suppl 1)","author":"Alveyn","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026081812493049000_rkag093-B31","doi-asserted-by":"crossref","first-page":"rkae091","DOI":"10.1093\/rap\/rkae091","article-title":"Patient initiated follow-up (PIFU): how can rheumatology departments start to reap the benefits? A consensus document","volume":"8","author":"Sengupta","year":"2024","journal-title":"Rheumatol Adv Pract"},{"key":"2026081812493049000_rkag093-B32","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12913-014-0579-0","article-title":"PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews","volume":"14","author":"Methley","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"2026081812493049000_rkag093-B33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"2026081812493049000_rkag093-B34","doi-asserted-by":"crossref","first-page":"107700","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107700","article-title":"Reliability of proxy reports on patient reported outcomes measures in stroke: an updated systematic review","volume":"33","author":"Reimer","year":"2024","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026081812493049000_rkag093-B35","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026081812493049000_rkag093-B36","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/annonc\/mdv181","article-title":"Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors","volume":"26","author":"Howell","year":"2015","journal-title":"Ann Oncol"},{"key":"2026081812493049000_rkag093-B37","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"2026081812493049000_rkag093-B38","article-title":"Guidance on the conduct of narrative synthesis in systematic reviews. A product from the ESRC methods programme. Version 1","author":"Popay","year":"2006"},{"key":"2026081812493049000_rkag093-B39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.13105\/wjma.v5.i4.80","article-title":"Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale","volume":"5","author":"Luchini","year":"2017","journal-title":"World J Meta-Anal"},{"key":"2026081812493049000_rkag093-B40","article-title":"The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2000"},{"key":"2026081812493049000_rkag093-B41","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/rheumatology\/kes008","article-title":"Treatment decisions and related costs differ significantly depending on the choice of a disease activity index in RA, according to 1987 and 2010 classification criteria","volume":"51","author":"de Jong","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"2026081812493049000_rkag093-B42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/rheumatology\/kes285","article-title":"Relative importance of doctor-reported outcomes vs patient-reported outcomes in DMARD intensification for rheumatoid arthritis: the DUO study","volume":"52","author":"Dougados","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"2026081812493049000_rkag093-B43","first-page":"899","article-title":"Arthritis education: the integration of patient-reported outcome measures and patient self-management","volume":"30","author":"El Miedany","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2026081812493049000_rkag093-B44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13075-019-2076-7","article-title":"Barriers to treatment optimization and achievement of patients\u2019 goals: perspectives from people living with rheumatoid arthritis enrolled in the ArthritisPower registry","volume":"22","author":"Gavigan","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2026081812493049000_rkag093-B45","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.3390\/jcm10235659","article-title":"Implementation of the treat-to-target concept in evaluation of psoriatic arthritis patients","volume":"10","author":"Gazitt","year":"2021","journal-title":"J Clin Med"},{"key":"2026081812493049000_rkag093-B46","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/annrheumdis-2011-200274","article-title":"A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry","volume":"71","author":"Schipper","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2026081812493049000_rkag093-B47","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s00296-023-05392-5","article-title":"Student-led clinics and ePROs to accelerate diagnosis and treatment of patients with axial spondyloarthritis: results from a prospective pilot study","volume":"43","author":"von Rohr","year":"2023","journal-title":"Rheumatol Int"},{"key":"2026081812493049000_rkag093-B48","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/03009742.2024.2406611","article-title":"Remote patient-reported outcome measure triage score for monitoring disease activity and allocation of consultations in rheumatoid arthritis patients","volume":"54","author":"van den Dikkenberg","year":"2025","journal-title":"Scand J Rheumatol"},{"key":"2026081812493049000_rkag093-B49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/acr.24114","article-title":"Treat-to-target approach in rheumatoid arthritis: a quality improvement trial","volume":"73","author":"Desai","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026081812493049000_rkag093-B50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/RHU.0000000000001883","article-title":"Probability of medication intensifications in rheumatoid arthritis patients with low disease activity scores on their patient-reported outcomes: a medical-records review study","volume":"28","author":"Seppen","year":"2022","journal-title":"J Clin Rheumatol"},{"key":"2026081812493049000_rkag093-B51","first-page":"1243","article-title":"Which variables best predict change in rheumatoid arthritis therapy in daily clinical practice?","volume":"33","author":"Soubrier","year":"2006","journal-title":"J Rheumatol"},{"key":"2026081812493049000_rkag093-B52","first-page":"129","article-title":"Treat-to-target approach in daily clinical practice in Pakistani patients with early rheumatoid arthritis","volume":"25","author":"Farman","year":"2015","journal-title":"J Coll Physicians Surg Pak"},{"key":"2026081812493049000_rkag093-B53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10067-016-3191-3","article-title":"Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry","volume":"35","author":"Steunebrink","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2026081812493049000_rkag093-B54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(04)16676-2","article-title":"Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial","volume":"364","author":"Grigor","year":"2004","journal-title":"Lancet"},{"key":"2026081812493049000_rkag093-B55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/ard.2008.097683","article-title":"DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis","volume":"69","author":"Goekoop-Ruiterman","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2026081812493049000_rkag093-B56","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/acr.24083","article-title":"Do patients with moderate or high disease activity escalate rheumatoid arthritis therapy according to treat-to-target principles? Results from the rheumatology informatics system for effectiveness registry of the American College of Rheumatology","volume":"72","author":"Yun","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026081812493049000_rkag093-B57","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10067-016-3405-8","article-title":"Rheumatologists\u2019 adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission","volume":"36","author":"Akdemir","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2026081812493049000_rkag093-B58","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0140-6736(14)60299-3","article-title":"Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a multicentre, open-label, randomised controlled trial","volume":"383","author":"Coates","year":"2014","journal-title":"Lancet"},{"key":"2026081812493049000_rkag093-B59","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/annrheumdis-2020-219585","article-title":"Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial","volume":"80","author":"Molto","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2026081812493049000_rkag093-B60","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/acr.25387","article-title":"When usual care is not so usual: protocol violations and generalizability in a treat-to-target strategy trial in patients with axial spondyloarthritis","volume":"76","author":"L\u00f3pez-Medina","year":"2024","journal-title":"Arthritis Care Res"},{"key":"2026081812493049000_rkag093-B61","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/rheumatology\/keab516","article-title":"Treat-to-target in axial spondyloarthritis: an observational study in daily practice","volume":"61","author":"Beckers","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026081812493049000_rkag093-B62","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s10067-015-2915-0","article-title":"Daily practice feasibility and effectiveness of treating long-standing rheumatoid arthritis to target with synthetic disease-modifying antirheumatic drugs: a prospective cohort study","volume":"34","author":"Brenol","year":"2015","journal-title":"Clin Rheumatol"},{"key":"2026081812493049000_rkag093-B63","first-page":"112","article-title":"Apilot trial of integrating the Patient-Reported Outcome Measurement InformationSystem (PROMIS\u00ae) into rheumatology care","volume":"43","author":"Gedert","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"2026081812493049000_rkag093-B64","doi-asserted-by":"crossref","first-page":"A150","DOI":"10.1136\/annrheumdis-2013-eular.489","article-title":"Impact of a nurse led program of patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDRA)","volume":"72(Suppl 3)","author":"Dougados","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2026081812493049000_rkag093-B65","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/rheumatology\/kead679","article-title":"How do patient reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients","volume":"64","author":"Coyle","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026081812493049000_rkag093-B66","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/art.42774","article-title":"A mobile health application integrated in the electronic health record for rheumatoid arthritis patient-reported outcomes: a controlled interrupted time-series analysis of impact on visit efficiency","volume":"76","author":"Solomon","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026081812493049000_rkag093-B67","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/art.42292","article-title":"Smartphone-assisted patient-initiated care versus usual care in patients with rheumatoid arthritis and low disease activity: a randomized controlled trial","volume":"74","author":"Seppen","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026081812493049000_rkag093-B68","doi-asserted-by":"crossref","first-page":"e000184","DOI":"10.1136\/rmdopen-2015-000184","article-title":"Patient-initiated appointments compared with standard outpatient care for rheumatoid arthritis: a randomised controlled trial","volume":"2","author":"Fredriksson","year":"2016","journal-title":"RMD Open"},{"key":"2026081812493049000_rkag093-B69","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/acr.23280","article-title":"Tele-health followup strategy for tight control of disease activity in rheumatoid arthritis: results of a randomized controlled trial","volume":"70","author":"de Thurah","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026081812493049000_rkag093-B70","doi-asserted-by":"crossref","first-page":"e000481","DOI":"10.1136\/rmdopen-2017-000481","article-title":"Efficacy of embedded nurse-led versus conventional physician-led follow-up in rheumatoid arthritis: a systematic review and meta-analysis","volume":"3","author":"de Thurah","year":"2017","journal-title":"RMD Open"},{"key":"2026081812493049000_rkag093-B71","doi-asserted-by":"crossref","first-page":"166","DOI":"10.4103\/2230-8210.129106","article-title":"Treat-to-target trials in diabetes","volume":"18","author":"Wangnoo","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"2026081812493049000_rkag093-B72","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.3390\/jcm12196292","article-title":"Benefits and challenges of treat-to-target in inflammatory bowel disease","volume":"12","author":"West","year":"2023","journal-title":"J Clin Med"},{"key":"2026081812493049000_rkag093-B73","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/104973299129122289","article-title":"Living with diabetes as a transformational experience","volume":"9","author":"Paterson","year":"1999","journal-title":"Qual Health Res"},{"key":"2026081812493049000_rkag093-B74","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jcjd.2022.06.002","article-title":"Exploring the lived experience of diabetes through an intersectional lens: a qualitative study of adults with type 1 and type 2 diabetes","volume":"46","author":"Jones","year":"2022","journal-title":"Can J Diabetes"},{"key":"2026081812493049000_rkag093-B75","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/SGA.0000000000000301","article-title":"Factors influencing the life experiences of individuals with inflammatory bowel disease","volume":"41","author":"Lopez-Cortes","year":"2018","journal-title":"Gastroenterol Nurs"},{"key":"2026081812493049000_rkag093-B76","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/CEG.S303688","article-title":"Patients\u2019 experiences and challenges in living with inflammatory bowel disease: a qualitative approach","volume":"14","author":"Popov","year":"2021","journal-title":"Clin Exp Gastroenterol"},{"key":"2026081812493049000_rkag093-B77","doi-asserted-by":"crossref","first-page":"e2424793","DOI":"10.1001\/jamanetworkopen.2024.24793","article-title":"Patient-reported outcome measures in cancer care: an updated systematic review and meta-analysis","volume":"7","author":"Balitsky","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026081812493049000_rkag093-B78","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-025-03507-y","article-title":"Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial","volume":"31","author":"Basch","year":"2025","journal-title":"Nat Med"},{"key":"2026081812493049000_rkag093-B79","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","article-title":"What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials","volume":"32","author":"Kotronoulas","year":"2014","journal-title":"J Clin Oncol"},{"key":"2026081812493049000_rkag093-B80","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/rheumatology\/keae223","article-title":"\u2018I couldn\u2019t carry on taking a drug like that\u2019: a qualitative study of patient perspectives on side effects from rheumatology drugs","volume":"64","author":"Berthelsen","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026081812493049000_rkag093-B81","doi-asserted-by":"crossref","first-page":"104998","DOI":"10.1016\/j.jbspin.2020.04.009","article-title":"Over-treatment in rheumatology","volume":"88","author":"Berthelot","year":"2021","journal-title":"Joint Bone Spine"},{"key":"2026081812493049000_rkag093-B82","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1136\/annrheumdis-2018-214199","article-title":"Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritis","volume":"78","author":"Ferreira","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2026081812493049000_rkag093-B83","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s41687-018-0061-6","article-title":"How do patient reported outcome measures (PROMs) support clinician-patient communication and patient care? A realist synthesis","volume":"2","author":"Greenhalgh","year":"2018","journal-title":"J Patient Rep Outcomes"},{"key":"2026081812493049000_rkag093-B84","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s11136-021-03003-z","article-title":"Perceived benefits and limitations of using patient-reported outcome measures in clinical practice with individual patients: a systematic review of qualitative studies","volume":"31","author":"Campbell","year":"2022","journal-title":"Qual Life Res"},{"key":"2026081812493049000_rkag093-B85","volume-title":"COSMIN methodology for assessing the content validity of PROMs. User manual","author":"Terwee","year":"2018"},{"key":"2026081812493049000_rkag093-B86","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-10-4068-9_9","article-title":"Developing patient-reported and relevant outcome measures","volume-title":"Patient involvement in health technology assessment","author":"Haywood","year":"2017"},{"key":"2026081812493049000_rkag093-B87","doi-asserted-by":"crossref","first-page":"rkaf101","DOI":"10.1093\/rap\/rkaf101","article-title":"Improved clinical care and capacity through an integrated electronic patient-reported outcome measure and health record system in inflammatory arthritis","volume":"9","author":"Chan","year":"2025","journal-title":"Rheumatol Adv Pract"},{"key":"2026081812493049000_rkag093-B88","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12916-018-1050-6","article-title":"Analysing the role of complexity in explaining the fortunes of technology programmes: empirical application of the NASSS framework","volume":"16","author":"Greenhalgh","year":"2018","journal-title":"BMC Med"},{"key":"2026081812493049000_rkag093-B89","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s41927-020-00143-6","article-title":"Patient-initiated follow-up (PIFU) as reorganized support for increased patient involvement \u2013 focus group discussions among patients\u2019 with inflammatory arthritis","volume":"4","author":"Bech","year":"2020","journal-title":"BMC Rheumatol"},{"key":"2026081812493049000_rkag093-B90","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41927-025-00481-3","article-title":"A theory of change for patient-initiated follow-up care in rheumatoid arthritis","volume":"9","author":"Ester","year":"2025","journal-title":"BMC Rheumatol"},{"key":"2026081812493049000_rkag093-B91","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1007\/s11136-020-02706-z","article-title":"Smartphone app for monitoring asthma in children and adolescents","volume":"30","author":"Mayoral","year":"2021","journal-title":"Quality Life Res"},{"key":"2026081812493049000_rkag093-B92","volume-title":"Newcastle-Ottawa quality assessment scale cohort studies","author":"Wells","year":"2014"},{"key":"2026081812493049000_rkag093-B93","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11136-018-2048-4","article-title":"Implementing patient-reported outcome measures in clinical practice: a companion guide to the ISOQOL user\u2019s guide","volume":"28","author":"Chan","year":"2019","journal-title":"Qual Life Res"},{"key":"2026081812493049000_rkag093-B94","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00296-015-3415-x","article-title":"A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective","volume":"36","author":"Taylor","year":"2016","journal-title":"Rheumatol Int"},{"key":"2026081812493049000_rkag093-B95","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s41687-020-00256-z","article-title":"User experiences on implementation of patient reported outcome measures (PROMs) in a haematological outpatient clinic","volume":"4","author":"Thestrup Hansen","year":"2020","journal-title":"J Patient Rep Outcomes"},{"key":"2026081812493049000_rkag093-B96","first-page":"1383","article-title":"Unmet supportive care needs in Hispanic\/Latino cancer survivors: prevalence and associations with patient-provider communication, satisfaction with cancer care, and symptom burden","volume":"27","author":"Moreno","year":"2019","journal-title":"Support Care Cancer"},{"key":"2026081812493049000_rkag093-B97","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1186\/s12913-022-08611-0","article-title":"Unmet health care needs: factors predicting satisfaction with health care services among community-dwelling Canadians living with neurological conditions","volume":"22","author":"Chambers-Richards","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"2026081812493049000_rkag093-B98","doi-asserted-by":"crossref","first-page":"bjgpopen20X101135","DOI":"10.3399\/bjgpopen20X101135","article-title":"Implementing PROMs in routine clinical care: a qualitative exploration of GP perspectives","volume":"5","author":"Litchfield","year":"2021","journal-title":"BJGP Open"},{"key":"2026081812493049000_rkag093-B99","doi-asserted-by":"crossref","first-page":"669869","DOI":"10.3389\/fdgth.2021.669869","article-title":"Artificial intelligence solutions to increase medication adherence in patients with non-communicable diseases","volume":"3","author":"Babel","year":"2021","journal-title":"Front Digit Health"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkag093\/69876114\/rkag093.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/10\/3\/rkag093\/69876114\/rkag093.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/10\/3\/rkag093\/69876114\/rkag093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:49:49Z","timestamp":1787071789000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkag093\/8740572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkag093","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rkag093"}}